Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis
Lili Zhang, Daniel A Zlotoff, Magid Awadalla, Syed S Mahmood, Anju Nohria, Malek Z O Hassan, Franck Thuny, Leyre Zubiri, Carol L Chen, Ryan J Sullivan, Raza M Alvi, Adam Rokicki, Sean P Murphy, Maeve Jones-O'Connor, Lucie M Heinzerling, Ana Barac, Brian J Forrestal, Eric H Yang, Dipti Gupta, Michael C Kirchberger, Sachin P Shah, Muhammad A Rizvi, Gagan Sahni, Anant Mandawat, Michael Mahmoudi, Sarju Ganatra, Stephane Ederhy, Eduardo Zatarain-Nicolas, John D Groarke, Carlo G Tocchetti, Alexander R Lyon, Paaladinesh Thavendiranathan, Justine V Cohen, Kerry L Reynolds, Michael G Fradley, Tomas G Neilan, Lili Zhang, Daniel A Zlotoff, Magid Awadalla, Syed S Mahmood, Anju Nohria, Malek Z O Hassan, Franck Thuny, Leyre Zubiri, Carol L Chen, Ryan J Sullivan, Raza M Alvi, Adam Rokicki, Sean P Murphy, Maeve Jones-O'Connor, Lucie M Heinzerling, Ana Barac, Brian J Forrestal, Eric H Yang, Dipti Gupta, Michael C Kirchberger, Sachin P Shah, Muhammad A Rizvi, Gagan Sahni, Anant Mandawat, Michael Mahmoudi, Sarju Ganatra, Stephane Ederhy, Eduardo Zatarain-Nicolas, John D Groarke, Carlo G Tocchetti, Alexander R Lyon, Paaladinesh Thavendiranathan, Justine V Cohen, Kerry L Reynolds, Michael G Fradley, Tomas G Neilan
No abstract availableKeywords: corticosteroid; immunotherapy; myocarditis.
Figures
References
- Mahmood SS, Fradley MG, Cohen JV, Nohria A, Reynolds KL, Heinzerling LM, Sullivan RJ, Damrongwatanasuk R, Chen CL, Gupta D, Kirchberger MC, Awadalla M, Hassan MZO, Moslehi JJ, Shah SP, Ganatra S, Thavendiranathan P, Lawrence DP, Groarke JD and Neilan TG. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. Journal of the American College of Cardiology. 2018;71:1755–1764.
- Awadalla M, Mahmood SS, Groarke JD, Hassan MZO, Nohria A, Rokicki A, Murphy SP, Mercaldo ND, Zhang L, Zlotoff DA, Reynolds KL, Alvi RM, Banerji D, Liu S, Heinzerling LM, Jones-O’Connor M, Bakar RB, Cohen JV, Kirchberger MC, Sullivan RJ, Gupta D, Mulligan CP, Shah SP, Ganatra S, Rizvi MA, Sahni G, Tocchetti CG, Lawrence DP, Mahmoudi M, Devereux RB, Forrestal BJ, Mandawat A, Lyon AR, Chen CL, Barac A, Hung J, Thavendiranathan P, Picard MH, Thuny F, Ederhy S, Fradley MG and Neilan TG. Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis. Journal of the American College of Cardiology. 2020;75:467–478.
- Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, Brassil KJ, Caterino JM, Chau I, Ernstoff MS, Gardner JM, Ginex P, Hallmeyer S, Holter Chakrabarty J, Leighl NB, Mammen JS, McDermott DF, Naing A, Nastoupil LJ, Phillips T, Porter LD, Puzanov I, Reichner CA, Santomasso BD, Seigel C, Spira A, Suarez-Almazor ME, Wang Y, Weber JS, Wolchok JD, Thompson JA and National Comprehensive Cancer N. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36:1714–1768.
- Puzanov I, Diab A, Abdallah K, Bingham CO 3rd, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL and Ernstoff MS. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. J Immunother Cancer. 2017;5:95.
- Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Helio T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P and Elliott PM. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European heart journal. 2013;34:2636–48, 2648a–2648d.
Source: PubMed